Kaye Edward M. MD

Kaye Edward M. MD is listed in filings as Director at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK), Cytokinetics, Incorporated - Common Stock (CYTK), and Avidity Biosciences Inc (RNAM). The current snapshot covers public activity from Dec 3, 2024 to Jun 5, 2026. Reported amounts are shown as $524.0K to $331.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.